Litigation Details for Coherus Biosciences, Inc. v. Amgen Inc. (D. Del. 2019)
✉ Email this page to a colleague
Coherus Biosciences, Inc. v. Amgen Inc. (D. Del. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-01-23 |
| Court | District Court, D. Delaware | Date Terminated | 2019-11-25 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | Plaintiff | Referred To | |
| Parties | COHERUS BIOSCIENCES, INC. | ||
| Patents | 10,155,039; 10,159,732; 10,159,733; 10,207,000 | ||
| Attorneys | Joseph E. Lasher | ||
| Firms | Fish & Richardson P.C. | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Coherus Biosciences, Inc. v. Amgen Inc.
The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Coherus Biosciences, Inc. v. Amgen Inc. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-01-23 | 1 | Complaint | United States Patent Nos. 10,155,039 (“the ’039 patent”), 10,159,732 (“the ’732 patent”), and 10,159,…and continues to infringe the ’039 patent, ’732 patent, and ’733 patent; B) A judgment permanently…further infringement of the ’039 patent, ’732 patent, and ’733 patent; C) A judgment awarding…Amgen’s infringement of the ’039 patent, ’732 patent, and ’733 patent was deliberate and willful; …10,159,733 (“the ’733 patent”) under the Patent Laws of the United States, 35 U.S.C. § 1 et seq. | External link to document |
| 2019-06-24 | 18 | Answer to Counterclaim | The Patents-In-Suit 112. U.S. Patent No. 10,155,039 (“the ’039 patent”), titled “Stable…Non-Infringement and Invalidity of U.S. Patent No. 10,155,039 117. Amgen restates and incorporates… U.S. Patent No. 9,114,166 (the “’166 patent”), U.S. Patent No. 8,916,157 (the “’157 patent”), and…Asserted Patents, for example, U.S. Patent No. 9,272,041 (the “’041 patent”) and U.S. Patent No. …and ’714 patents are more relevant than the ’166 patent, the ’157 patent, and the ’583 patent to the | External link to document |
| 2019-01-23 | 3 | Patent/Trademark Report to Commissioner | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 10,155,039; US 10,159,732; US… 26 November 2019 1:19-cv-00139 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| 2019-11-25 | 53 | Order | Amgen") for infringement of U .S. Patent Nos. 10,155 ,039, 10, 159,732, and 10,159,733 on January…WHEREAS, Coherus amended its complaint to add U.S. Patent No. 10,207,000 on March 5, 2019 (D.I. 7); …non-infringement, invalidity, and unenforceability of the patents-in-suit on April 18, 2019 (D.I. 10); IT… 26 November 2019 1:19-cv-00139 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
